Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Marchetti

Showing results (141-150 of 187) with videos related to

Pageof 19
Sort By:
International Journal of Public Health|August 23, 2023
Access to Vaccination for Newly Arrived Migrants: Developing a General Conceptual Framework for Understanding How to Improve Vaccination Coverage in European CountriesSalvatore Scarso, Giulia Marchetti, Maria Laura Russo, et al.
Antiviral Therapy|October 1, 2004
Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trialAndrea Gori, Daria Trabattoni, Alessandra Bandera, et al.
Frontiers in Public Health|June 28, 2021
A Quantitative Estimate of the Expected Shortening of the Median Isolation Period of Patients With COVID-19 After the Adoption of a Symptom-Based StrategyFrancesca Bai, Alessandro Tavelli, Giovanni Mulè, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2018
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ARTFrancesca Ceccherini-Silberstein, Alessandro Cozzi Lepri, Claudia Alteri, et al.
International Journal of STD & AIDS|January 8, 2025
Effectiveness, safety, and patient-reported outcomes of bictegravir/emtricitabine/tenofovir alafenamide in routine clinical care in Italy: 12-Month results from the BICSTaR cohortAndrea Antinori, Giulia Marchetti, Vincenzo Esposito, et al.
Open Forum Infectious Diseases|March 18, 2026
Early Combination Antiretroviral Therapy Initiation During Primary HIV Infection Restricts HIV Reservoirs and Gut-Driven Inflammation but Fails to Rewire the Systemic Cytokine LandscapeValeria Bono, Camilla Tincati, Matteo Augello, et al.
International Journal of Antimicrobial Agents|May 20, 2024
Plasma, intracellular and lymph node antiretroviral concentrations and HIV DNA change during primary HIV infection: Results from the INACTION P25 studyAmedeo De Nicolò, Alice Palermiti, Stefania Dispinseri, et al.
Jac-Antimicrobial Resistance|June 19, 2026
Current practices and challenges in the management of acute bacterial skin and skin structure infections (ABSSSI): results from an Italian multicentre survey with expert discussionLidia Gazzola, Matteo Augello, Silvia Cavinato, et al.
AIDS (London, England)|November 28, 2023
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocationCamilla Tincati, Valeria Bono, Elvira Stefania Cannizzo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2024
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis - results from the ICONA cohort in Italy, 2009-2022Annalisa Mondi, Alessandro Cozzi-Lepri, Alessandro Tavelli, et al.
Pageof 19

Showing results (141-150 of 187) with videos related to

Sort By:
Pageof 19
International Journal of Public Health|August 23, 2023
Access to Vaccination for Newly Arrived Migrants: Developing a General Conceptual Framework for Understanding How to Improve Vaccination Coverage in European CountriesSalvatore Scarso, Giulia Marchetti, Maria Laura Russo, et al.
Antiviral Therapy|October 1, 2004
Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trialAndrea Gori, Daria Trabattoni, Alessandra Bandera, et al.
Frontiers in Public Health|June 28, 2021
A Quantitative Estimate of the Expected Shortening of the Median Isolation Period of Patients With COVID-19 After the Adoption of a Symptom-Based StrategyFrancesca Bai, Alessandro Tavelli, Giovanni Mulè, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2018
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ARTFrancesca Ceccherini-Silberstein, Alessandro Cozzi Lepri, Claudia Alteri, et al.
International Journal of STD & AIDS|January 8, 2025
Effectiveness, safety, and patient-reported outcomes of bictegravir/emtricitabine/tenofovir alafenamide in routine clinical care in Italy: 12-Month results from the BICSTaR cohortAndrea Antinori, Giulia Marchetti, Vincenzo Esposito, et al.
Open Forum Infectious Diseases|March 18, 2026
Early Combination Antiretroviral Therapy Initiation During Primary HIV Infection Restricts HIV Reservoirs and Gut-Driven Inflammation but Fails to Rewire the Systemic Cytokine LandscapeValeria Bono, Camilla Tincati, Matteo Augello, et al.
International Journal of Antimicrobial Agents|May 20, 2024
Plasma, intracellular and lymph node antiretroviral concentrations and HIV DNA change during primary HIV infection: Results from the INACTION P25 studyAmedeo De Nicolò, Alice Palermiti, Stefania Dispinseri, et al.
Jac-Antimicrobial Resistance|June 19, 2026
Current practices and challenges in the management of acute bacterial skin and skin structure infections (ABSSSI): results from an Italian multicentre survey with expert discussionLidia Gazzola, Matteo Augello, Silvia Cavinato, et al.
AIDS (London, England)|November 28, 2023
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocationCamilla Tincati, Valeria Bono, Elvira Stefania Cannizzo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2024
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis - results from the ICONA cohort in Italy, 2009-2022Annalisa Mondi, Alessandro Cozzi-Lepri, Alessandro Tavelli, et al.
Pageof 19